{"created":"2023-06-19T11:39:37.257434+00:00","id":7732,"links":{},"metadata":{"_buckets":{"deposit":"83b3b599-a2fa-437b-8d5f-5794060bf433"},"_deposit":{"created_by":16,"id":"7732","owners":[16],"pid":{"revision_id":0,"type":"depid","value":"7732"},"status":"published"},"_oai":{"id":"oai:mie-u.repo.nii.ac.jp:00007732","sets":["334:608:614:615"]},"author_link":[],"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2013-01-01","bibliographicIssueDateType":"Issued"}}]},"item_7_date_granted_59":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2013-12-18"}]},"item_7_degree_grantor_57":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"三重大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"14101","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_7_degree_name_56":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_7_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_7_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"内容の要旨・審査結果の要旨 / 三重大学大学院医学系研究科生命医科学専攻病態修復医学講座肝胆膵・移植外科学分野","subitem_description_type":"Other"}]},"item_7_dissertation_number_60":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲医学第1649号"}]},"item_7_publisher_30":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"三重大学"}]},"item_7_text_65":{"attribute_name":"資源タイプ（三重大）","attribute_value_mlt":[{"subitem_text_value":"Doctoral Dissertation / 博士論文"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小林, 基之","creatorNameLang":"ja"},{"creatorName":"コバヤシ, モトユキ","creatorNameLang":"ja-Kana"},{"creatorName":"Kobayashi, Motoyuki","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-18"}],"displaytype":"detail","filename":"2013DM015-1.pdf","filesize":[{"value":"107.8 kB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"内容の要旨","url":"https://mie-u.repo.nii.ac.jp/record/7732/files/2013DM015-1.pdf"},"version_id":"80805ff4-db24-4d3c-9dcb-2577ba7b44a9"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-18"}],"displaytype":"detail","filename":"2013DM015-2.pdf","filesize":[{"value":"248.0 kB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"審査結果の要旨","url":"https://mie-u.repo.nii.ac.jp/record/7732/files/2013DM015-2.pdf"},"version_id":"1f89007e-acf5-46b6-b47e-633296ebf627"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma : significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter-1 expression","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma : significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter-1 expression","subitem_title_language":"en"}]},"item_type_id":"7","owner":"16","path":["615"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2014-04-15"},"publish_date":"2014-04-15","publish_status":"0","recid":"7732","relation_version_is_last":true,"title":["Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma : significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter-1 expression"],"weko_creator_id":"16","weko_shared_id":-1},"updated":"2023-11-08T04:25:37.014170+00:00"}